The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2024 |
Milad Taghizadeh Anvar, Kimiya Rashidan, Nima Arsam, Ashkan Rasouli-Saravani, Hamidreza Yadegari, Ali Ahmadi, Zeynab Asgari, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad, Safa Tahmasebi. Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?, Cancer Cell International. 2024; 24: 355. https://doi.org/10.1186/s12935-024-03525-9 |
|
2 |
2024 |
Eric Jou, 2024; 209: 1. https://doi.org/10.1016/bs.pmbts.2024.03.036 |
|
3 |
2024 |
Julia Meidenbauer, Matthias Wachter, Sebastian R. Schulz, Nada Mostafa, Lilli Zülch, Benjamin Frey, Rainer Fietkau, Udo S. Gaipl, Tina Jost. Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC, Frontiers in Oncology. 2024; 14: 1460150. https://doi.org/10.3389/fonc.2024.1460150 |
|
4 |
2024 |
Eric Jou, Natasha Chaudhury, Fizza Nasim. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment, Exploration of Targeted Anti-tumor Therapy. 2024; 5: 187. https://doi.org/10.37349/etat.2024.00212 |
|
5 |
2024 |
Sunanda Rajkumari, Jaspreet Singh, Usha Agrawal, Sandeep Agrawal. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives, International Immunopharmacology. 2024; 142: 112949112949. https://doi.org/10.1016/j.intimp.2024.112949 |
|
6 |
2024 |
Ludovica Lopresti, Vanessa Tatangelo, Cosima T. Baldari, Laura Patrussi. Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy, Frontiers in Immunology. 2024; 15: 1418527. https://doi.org/10.3389/fimmu.2024.1418527 |
|
7 |
2024 |
James Michael Verner, Harry Frederick Arbuthnott, Raghavskandhan Ramachandran, Manini Bharadwaj, Natasha Chaudhury, Eric Jou. Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy, Exploration of Targeted Anti-tumor Therapy. 2024; 5: 296. https://doi.org/10.37349/etat.2024.00219 |
|
8 |
2025 |
Annamaria Colacci, Emanuela Corsini, Miriam Naomi Jacobs. Addressing Immune Response Dysfunction in an Integrated Approach for Testing and Assessment for Non-Genotoxic Carcinogens in Humans: A Targeted Analysis, International Journal of Molecular Sciences. 2025; 26: 6310. https://doi.org/10.3390/ijms26136310 |
|
9 |
2024 |
James Michael Verner, Harry Frederick Arbuthnott, Raghavskandhan Ramachandran, Manini Bharadwaj, Natasha Chaudhury, Eric Jou. Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy, Exploration of Targeted Anti-tumor Therapy. 2024; 5: 296. https://doi.org/10.37349/etat.2024.00219 |
|
10 |
2024 |
Hesam Abouali, Michelle Przedborski, Mohammad Kohandel, Mahla Poudineh. Investigating nano-sized tumor-derived extracellular vesicles in enhancing anti-PD-1 immunotherapy, Nanoscale. 2024; 16: 19062. https://doi.org/10.1039/D4NR00729H |